[1. Wyatt CM, Winston JA, Malvestutto CD, Fishbein DA, Barash I, Cohen AJ, et al. Chronic kidney disease in HIV infection: an urban epidemic. AIDS. 2007 Oct 1;21(15):2101-3.10.1097/QAD.0b013e3282ef1bb417885301]Search in Google Scholar
[2. Szczech LA, Gupta SK, Habash R, Guasch A, Kalayjian R, Appel R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004 Sep;66(3):1145-52.10.1111/j.1523-1755.2004.00865.x15327410]Search in Google Scholar
[3. Swanepoel CR, Atta MG, D’Agati VD, Estrella MM, Fogo AB, Naicker S, et al. Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2018 Mar;93(3):545-59.]Search in Google Scholar
[4. Streinu-Cercel A, Sandulescu O, Poiana C, Dorobantu M, Mircescu G, Lazureanu VE, et al. Consensus statement on the assessment of comorbidities in people living with HIV in Romania. Germs. 2019 Dec;9(4):198-210.10.18683/germs.2019.1178694265532042727]Search in Google Scholar
[5. Crum-Cianflone N, Ganesan A, Teneza-Mora N, Riddle M, Medina S, Barahona I, et al. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS Patient Care STDS. 2010;24(6):353-6010.1089/apc.2009.0326293356120515419]Search in Google Scholar
[6. Campbell LJ, Ibrahim F, Fisher M, Holt SG, Hendry BM, Post FA. Spectrum of chronic kidney disease in HIV-infected patients. HIV Med. 2009 Jul;10(6):329-36.10.1111/j.1468-1293.2008.00691.x19226409]Search in Google Scholar
[7. Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008 Jun 1;197(11):1548-57.10.1086/587994255320918422458]Search in Google Scholar
[8. Morlat P, Vivot A, Vandenhende MA, Dauchy FA, Asselineau J, Deti E, et al. Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012. PLoS One. 2013;8(6):e66223.10.1371/journal.pone.0066223368043923776637]Search in Google Scholar
[9. Kalayjian RC, Lau B, Mechekano RN, Crane HM, Rodriguez B, Salata RA, et al. Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care. AIDS. 2012 Sep 24;26(15):1907-15.10.1097/QAD.0b013e328357f5ed353162822824630]Search in Google Scholar
[10. Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010 Jul 17;24(11):1667-7810.1097/QAD.0b013e328339fe5320523203]Search in Google Scholar
[11. Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, et al. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015 Mar;12(3):e1001809.10.1371/journal.pmed.1001809438041525826420]Search in Google Scholar
[12. Yombi JC, Pozniak A, Boffito M, Jones R, Khoo S, Levy J, et al. Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity. AIDS. 2014 Mar 13;28(5):621-32.10.1097/QAD.000000000000010324983540]Search in Google Scholar
[13. Milburn J, Jones R, Levy JB. Renal effects of novel antiretroviral drugs. Nephrol Dial Transplant. 2017 Mar 1;32(3):434-9.]Search in Google Scholar
[14. EACS European AIDS Clinical Society. Guidelines. Version 10.0 November 2019. 2019.]Search in Google Scholar
[15. Kirkpatrick JJ, Leslie SW. Horseshoe Kidney. StatPearls: StatPearls Publishing; 2018.]Search in Google Scholar
[16. Taghavi K, Kirkpatrick J, Mirjalili SA. The horseshoe kidney: Surgical anatomy and embryology. J Pediatr Urol. 2016 Oct;12(5):275-80.10.1016/j.jpurol.2016.04.03327324557]Search in Google Scholar
[17. Natsis K, Piagkou M, Skotsimara A, Protogerou V, Tsitouridis I, Skandalakis P. Horseshoe kidney: a review of anatomy and pathology. Surg Radiol Anat. 2014 Aug;36(6):517-26.10.1007/s00276-013-1229-724178305]Search in Google Scholar
[18. Glodny B, Petersen J, Hofmann KJ, Schenk C, Herwig R, Trieb T, et al. Kidney fusion anomalies revisited: clinical and radiological analysis of 209 cases of crossed fused ectopia and horseshoe kidney. BJU Int. 2009 Jan;103(2):224-35.10.1111/j.1464-410X.2008.07912.x18710445]Search in Google Scholar
[19. Neville H, Ritchey ML, Shamberger RC, Haase G, Perlman S, Yoshioka T. The occurrence of Wilms tumor in horseshoe kidneys: a report from the National Wilms Tumor Study Group (NWTSG). J Pediatr Surg. 2002 Aug;37(8):1134-7.10.1053/jpsu.2002.3445812149688]Search in Google Scholar
[20. Huang EY, Mascarenhas L, Mahour GH. Wilms’ tumor and horseshoe kidneys: a case report and review of the literature. J Pediatr Surg. 2004 Feb;39(2):207-12.10.1016/j.jpedsurg.2003.10.01914966742]Search in Google Scholar
[21. Pawar AS, Thongprayoon C, Cheungpasitporn W, Sakhuja A, Mao MA, Erickson SB. Incidence and characteristics of kidney stones in patients with horseshoe kidney: A systematic review and meta-analysis. Urol Ann. 2018 Jan-Mar;10(1):87-93.10.4103/UA.UA_76_17579146529416282]Search in Google Scholar
[22. Suwannakhan A, Meemon K. Horseshoe kidney with extrarenal calyces and malformed renal vessels. Eur J Anat. 2016;20:355-9.]Search in Google Scholar
[23. Al Otay A, Sarhan O, El-Tholoth HS, Alhelaly A, Al Akrash H, Al Ghanbar M, et al. Different managements of horseshoe kidney stones, any difference in the outcome? Urology annals. 2018 Jul-Sep;10(3):287-90.10.4103/UA.UA_116_17606060130089987]Search in Google Scholar
[24. Hamada Y, Nishijima T, Watanabe K, Komatsu H, Tsukada K, Teruya K, et al. High incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapy. Clin Infect Dis. 2012 Nov;55(9):1262-9.10.1093/cid/cis62122820542]Search in Google Scholar
[25. Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, et al. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. J Infect Dis. 2013 May 1;207(9):1359-69.10.1093/infdis/jit043361042423382571]Search in Google Scholar
[26. Perazella MA. Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy. Kidney Int. 2010 Dec;78(11):1060-3.10.1038/ki.2010.34421076445]Search in Google Scholar
[27. Waheed S, Attia D, Estrella MM, Zafar Y, Atta MG, Lucas GM, et al. Proximal tubular dysfunction and kidney injury associated with tenofovir in HIV patients: a case series. Clin Kidney J. 2015 Aug;8(4):420-5.10.1093/ckj/sfv041451589626251709]Search in Google Scholar
[28. Gupta SK, Post FA, Arribas JR, Eron JJ, Jr., Wohl DA, Clarke AE, et al. Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials. Aids. 2019 Jul 15;33(9):1455-65.10.1097/QAD.0000000000002223663504330932951]Search in Google Scholar